Phase 1 study of XL119, a rebeccamycin analog, in patients...

Cancer 2008 Vol. 113; Iss. 2

Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies

Gautam Borthakur, Yesid Alvarado, Farhad Ravandi-Kashani, Jorge Cortes, Zeev Estrov, Stefan Faderl, Percy Ivy, Carlos Bueso-Ramos, B. Nebiyou Bekele, Francis Giles
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
113
Year:
2008
Language:
english
Pages:
7
DOI:
10.1002/cncr.23559
File:
PDF, 271 KB
english, 2008
Conversion to is in progress
Conversion to is failed